GLP-1 medications like Ozempic (semaglutide), Wegovy, and Mounjaro (tirzepatide) have transformed treatment for type 2 diabetes and weight loss — but they can also cause digestive side effects like nausea, diarrhea, constipation, bloating, and stomach pain that leave many patients confused or worried.
In this episode, we’re joined by Dr. Catherine Hudson from LSU Health New Orleans to separate fact from fiction and provide clear, evidence-based guidance. Dr. Hudson breaks down:
How GLP-1 receptor agonists work
Common digestive side effects—and how to manage them
Why lifestyle changes still matter
What you need to know before surgery or GI procedures when taking these medications
Whether you’re a patient, caregiver, or healthcare provider, this episode offers practical insights to help you navigate the GLP-1 journey with confidence.
This episode is presented in collaboration with the American College of Gastroenterology’s Patient Care Committee.
